Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after ...

Stroke is the leading cause of long-term disability and preventable disability in the United States. It is also the fifth leading cause of death, killing nearly 130,000 people in the U.S. each year.

Only a third of patients with acute stroke who receive intravenous tissue plasminogen activator (tPA) within 3 h of stroke onset achieve complete recanalization. One reason for a poor response to tPA ...

Endovascular therapy for acute ischemic stroke is generally avoided when the infarction is large, but the effect of endovascular therapy with medical care as compared with medical care alone for large ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.

The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...

PHOENIX, AZ—IV tirofiban lessens early neurological deterioration when given within 24 hours of symptom onset in patients with an acute noncardioembolic ischemic stroke who aren’t treated with IV ...

Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said. It is ...

An earlier start to anticoagulation after an acute ischemic stroke for patients found to have atrial fibrillation appeared safe and possibly improved outcomes, according to the randomized ELAN trial.

The role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations. We conducted a multicenter, prospective, open-label, randomized ...